we developed specific tools to help nurses and other clinicians know when to escalate a patient’s treatment to the shock pathway.” Educating the nursing team was one of the primary elements of the ...

Windtree Therapeutics, Inc. (NasdaqCM: WINT) recently showcased promising data on istaroxime, an investigational treatment ...

The article "Improving Cardiogenic Shock Team Activation ... and other clinicians know when to escalate a patient's treatment to the shock pathway." Educating the nursing team was one of the ...

The year held a number of surprises, including a few negative studies, as well as a big win for Impella in DanGer Shock.

Progress in assessing cardiovascular risk and identifying early prevention opportunities, improvements in treating heart failure, new therapies for bleeding strokes, strategies for reducing the ...

[Impact of VA-ECMO combined with IABP and timing on outcome of patients with acute myocardial infarction complicated with cardiogenic shock ... repair system in the treatment of patients ...